An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis

NCT01670045 ·Status: COMPLETED

Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab

NCT01752855 ·Status: COMPLETED ·Phase: PHASE2

Post-marketing Observational Study in Subjects With Rheumatoid Arthritis

NCT00234884 ·Status: COMPLETED

Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)

NCT01064856 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Efficacy With Respect to Clinical Improvement in Disease Activity and Safety of Tocilizumab in Patients Wtih Active Rheumatoid Arthritis.

NCT00754559 ·Status: COMPLETED ·Phase: PHASE3

Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis

NCT00233558 ·Status: TERMINATED ·Phase: PHASE4

Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis

NCT00867516 ·Status: COMPLETED ·Phase: PHASE2

Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis

NCT03110094 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis

NCT05467995 ·Status: COMPLETED ·Phase: PHASE2

A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

NCT02097264 ·Status: WITHDRAWN ·Phase: PHASE2

Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)

NCT00235885 ·Status: COMPLETED ·Phase: PHASE3

Fecal Microbiota Transplantation in Axial Spondyloarthritis

NCT06451588 ·Status: RECRUITING ·Phase: PHASE2

PRECISion medicinE Across the Disease Continuum to Prevent and Treat Rheumatoid Arthritis

NCT04482335 ·Status: UNKNOWN

Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis

NCT00085644 ·Status: COMPLETED ·Phase: PHASE3

Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis

NCT00649545 ·Status: APPROVED_FOR_MARKETING

Identification of Novel Molecular Targets for Rheumatoid Arthritis Patients

NCT04201535 ·Status: UNKNOWN

Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis

NCT01114880 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis

NCT01282255 ·Status: COMPLETED ·Phase: PHASE2

Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis

NCT02277574 ·Status: COMPLETED ·Phase: PHASE1

Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA

NCT03561649 ·Status: COMPLETED ·Phase: NA

A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis

NCT00448383 ·Status: COMPLETED ·Phase: PHASE3

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

NCT00235833 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)

NCT01565122 ·Status: COMPLETED

An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)

NCT00478660 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate

NCT01224418 ·Status: COMPLETED ·Phase: PHASE4